Clinical Trials Directory

Trials / Sponsors / Binhui Biopharmaceutical Co., Ltd.

Binhui Biopharmaceutical Co., Ltd.

Industry · 14 registered clinical trials — 9 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingOH2 Administered by Intratumoral Injection
Solid Tumor
Phase 12025-09-01
SuspendedoHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection
Solid Tumor
Phase 12023-12-19
TerminatedFirst-line Maintenance of OH2 Injection for Advanced Colorectal Cancer
Advanced Colorectal Carcinoma
Phase 22023-10-17
RecruitingOH2 Injection in Combination With BS006 Injection for Advanced Solid Tumors
Solid Tumor
Phase 1 / Phase 22023-09-07
RecruitingOH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer
Advanced Liver Cancer
Phase 12023-05-05
RecruitingOH2 Injection in Melanoma
Melanoma
Phase 32023-03-08
TerminatedClinical Trial of Safety and Immunogenicity of Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cells) as Booster
COVID-19
EARLY_Phase 12022-07-13
RecruitingOH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer
Non-muscle-invasive Bladder Cancer
Phase 1 / Phase 22022-07-11
TerminatedOH2 Oncolytic Viral Therapy in Advanced Bladder Cancer
Advanced Bladder Carcinoma
Phase 22022-05-25
RecruitingOH2 Oncolytic Viral Therapy in Central Nervous System Tumors
Central Nervous System Tumors
Phase 1 / Phase 22021-11-16
TerminatedOH2 Oncolytic Viral Therapy in Pancreatic Cancer
Pancreatic Cancer
Phase 1 / Phase 22021-02-02
RecruitingOH2 Injection in Combination With HX008 for Melanoma.
Melanoma
Phase 1 / Phase 22020-12-01
RecruitingOH2 Oncolytic Viral Therapy in Solid Tumors
Solid Tumor, Gastrointestinal Cancer
Phase 1 / Phase 22019-04-02
RecruitingOH2 Injection in Solid Tumors
Solid Tumor, Melanoma
Phase 1 / Phase 22018-11-22